サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1462912

造血幹細胞移植（HSCT）市場：移植タイプ別、用途別、適応症別、流通チャネル別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Hematopoietic Stem Cell Transplantation Market, By Transplant Type, By Application, By Indication, By Distribution Channel, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
造血幹細胞移植（HSCT）市場：移植タイプ別、用途別、適応症別、流通チャネル別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

造血幹細胞移植市場規模は2023年に28億2,312万米ドルとなり、2024年から2032年にかけてCAGR 10.7％で拡大

造血幹細胞移植市場- 市場力学

白血病とリンパ腫患者の増加が市場需要を促進

造血幹細胞移植市場は、白血病やリンパ腫の罹患率の増加により、より急速に拡大すると予測されています。米国では、白血病、リンパ腫、骨髄腫の診断が176,200回、リンパ性白血病と骨髄腫の生存が1,399,180例であることが、白血病リンパ腫協会の2019年報告書で明らかになった。造血幹細胞移植（HSCT）市場は、罹患率の増加により拡大が見込まれています。

造血幹細胞移植市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約10.7%のCAGRで毎年成長すると予測されています。

移植の種類別では、自己移植セグメントが予測期間中最大の市場シェアを占めると予測されます。

用途別では、骨髄幹細胞移植が予測期間中に大きな市場シェアを占める見込みです。

地域別では、北米が2023年の売上高でトップです。

造血幹細胞移植市場-セグメンテーション分析：

世界の造血幹細胞移植市場は、移植タイプ用途、適応症、エンドユーザー、治療領域、地域に基づいてセグメント化されます。

移植タイプでは、造血幹細胞移植市場は自己移植、同種移植、その他に区分されます。技術の進歩、血液疾患の有病率の増加、幹細胞治療の応用拡大により、予測期間中、自己移植分野が最大の市場シェアを占めると予想されます。

造血幹細胞移植産業は、用途では、臍帯幹細胞移植、骨髄幹細胞移植、末梢幹細胞移植、その他に二分されます。骨髄幹細胞移植分野は、予測期間中に大きな市場シェアを占めると予想されています。骨髄幹細胞移植の主な適応症には、骨髄に影響を及ぼす非悪性疾患や様々な血液悪性腫瘍が含まれます。これらには、リンパ腫、骨髄異形成症候群、再生不良性貧血、急性および慢性白血病、赤血球の生成に影響を及ぼす特定の遺伝性疾患などが含まれます。

適応症では、市場は白血病、リンパ増殖性疾患、非悪性疾患、その他に二分されます。

流通チャネル別では、オフラインとオンラインに二分されます。

エンドユーザーに基づき、造血幹細胞移植市場は小売薬局、病院薬局、専門クリニックに二分されます。

造血幹細胞移植市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。予測期間中、北米が最大の市場シェアを占めると予想されています。北米地域の市場は主に、白血病患者数の増加や研究開発における政府・民間部門の支出の増加といった要因によって牽引されています。例えば、カナダがん協会が2022年5月に発表した統計によると、2022年に6,700人のカナダ人が白血病の診断を受けると予測されています。さらに、2,700人の女性が白血病の診断を受け、そのうち1,300人が亡くなり、4,000人の男性が白血病の診断を受けると述べています。

造血幹細胞移植市場-競合情勢：

市場の主要企業は、Pfizer Inc., Akari Therapeutics, Plc, Otsuka America Pharmaceutical, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Lonza, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Sanofi, FUJIFILM Holdings Corporation, bluebird bio, Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Kiadis Pharma, Taiga Biotechnologies, Inc., CellGenix GmbH, Escape Therapeutics, Inc., Marker Therapeutics, Inc. and Talaris Therapeutics.

目次

第1章 造血幹細胞移植市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 造血幹細胞移植の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 造血幹細胞移植産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 造血幹細胞移植市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 造血幹細胞移植市場情勢

  • 造血幹細胞移植市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 造血幹細胞移植市場- 移植タイプ別

  • 概要
    • 移植タイプ別セグメントシェア分析
    • 自己移植
    • 同種異系
    • その他

第8章 造血幹細胞移植市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 臍帯幹細胞移植
    • 骨髄幹細胞移植
    • 末梢血幹細胞移植
    • その他

第9章 造血幹細胞移植市場- 適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • 白血病
    • リンパ増殖性疾患
    • 非悪性疾患
    • その他

第10章 造血幹細胞移植市場- 流通チャネル別

  • 概要
    • 流通チャネル別セグメントシェア分析
    • オフライン
    • オンライン

第11章 造血幹細胞移植市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 小売薬局
    • 病院薬局
    • 専門クリニック

第12章 造血幹細胞移植市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析- 造血幹細胞移植業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • Akari Therapeutics, Plc
    • Otsuka America Pharmaceutical, Inc.
    • Merck KGaA
    • Takeda Pharmaceutical Company Limited
    • Lonza
    • GlaxoSmithKline plc
    • Novartis AG
    • Merck &Co., Inc.
    • Sanofi
    • FUJIFILM Holdings Corporation
    • bluebird bio, Inc.
    • Pluristem Therapeutics Inc.
    • Regen Biopharma Inc.
    • Kiadis Pharma
    • Taiga Biotechnologies, Inc.
    • CellGenix GmbH
    • Escape Therapeutics, Inc.
    • Talaris Therapeutics
    • Marker Therapeutics, Inc.

第14章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hematopoietic Stem Cell Transplantation Market: Transplant Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Transplant Type
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Transplant Type 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Application 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Indication 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by End User 2019-2032 (USD Million)
  • TABLE Hematopoietic Stem Cell Transplantation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hematopoietic Stem Cell Transplantation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE North America Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Transplant Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hematopoietic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2370

REPORT HIGHLIGHT

Hematopoietic Stem Cell Transplantation Market size was valued at USD 2,823.12 Million in 2023, expanding at a CAGR of 10.7% from 2024 to 2032.

Many cancer forms and other illnesses can be treated with hematopoietic stem cell transplantation (HSCT). Two different sources of stem cells are bone marrow and blood. Hematopoietic stem cells are the young, immature blood cells found in bone marrow. The proportion of these blood cells that mature in the bone marrow and enter the bloodstream is quite low. The cells that reach the bloodstream are known as peripheral blood stem cells. After chemotherapy or radiation therapy, healthy hematopoietic stem cells are transplanted to replace absent, sick, or damaged hematopoietic stem cells.

Hematopoietic Stem Cell Transplantation Market- Market Dynamics

Increasing cases of leukemia and lymphoma to propel market demand

The market for hematopoietic stem cell transplantation is predicted to rise more rapidly due to the increased incidence of leukemia and lymphoma. In the United States, leukemia, lymphoma, or myeloma diagnosed 176,200 times, and lymph leukemia and myeloma survived in 1,399,180 cases, according to the Leukemia and Lymphoma Society's 2019 report. The market for hematopoietic stem cell transplantation (HSCT) is expected to grow as a result of the increasing incidence rate.

Hematopoietic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.7% over the forecast period (2024-2032)

Based on transplant type segmentation, the Autologous segment is expected to hold the largest market share over the forecast period

Based on application segmentation, the Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period

Based on region, North America was the leading revenue generator in 2023

Hematopoietic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Hematopoietic Stem Cell Transplantation Market is segmented based on Transplant Type Application, Indication, End User, Therapeutic Area, and Region.

Based on the transplant type, the Hematopoietic Stem Cell Transplantation market is segmented into Autologous, Allogeneic and Others. The Autologous segment is expected to hold the largest market share over the forecast period due to advancements in technology, increased prevalence of hematological disorders, and expanding applications of stem cell therapies.

Based on the application, the Hematopoietic Stem Cell Transplantation industry is bifurcated into Cord Stem Cell Transplant, Bone Marrow Stem Cell Transplant, Peripheral Stem Cell Transplant and Others. The Bone Marrow Stem Cell Transplant segment is expected to hold a significant market share over the projected period. The main indications for bone marrow stem cell transplantation include non-malignant bone marrow-affecting diseases and a variety of hematological malignancies. These could include lymphomas, myelodysplastic syndromes, aplastic anemia, acute and chronic leukemias, and specific hereditary illnesses that impact the generation of red blood cells.

Based on the indication, the market is bifurcated into Leukemia, Lymphoproliferative Disorders, Non-Malignant Disorders and Others.

Based on the distribution channel, the industry is bifurcated into Offline and Online.

Based on the end user, the Hematopoietic Stem Cell Transplantation market is bifurcated into Retail Pharmacy, Hospital Pharmacy and Specialty Clinics.

Hematopoietic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share over the forecast period. The market in the North American area is primarily driven by factors such as the rising number of leukemia patients and increased governmental and private sector expenditure in research and development. For instance, statistics released in May 2022 by the Canadian Cancer Society indicates that 6,700 Canadians are anticipated to receive a leukemia diagnosis year 2022. Additionally, it stated that 2,700 women will receive a leukemia diagnosis, 1,300 of them will pass away, and 4,000 males will receive a leukemia diagnosis.

Hematopoietic Stem Cell Transplantation Market- Competitive Landscape:

The key players in the market are Pfizer Inc., Akari Therapeutics, Plc, Otsuka America Pharmaceutical, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Lonza, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Sanofi, FUJIFILM Holdings Corporation, bluebird bio, Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Kiadis Pharma, Taiga Biotechnologies, Inc., CellGenix GmbH, Escape Therapeutics, Inc., Marker Therapeutics, Inc. and Talaris Therapeutics.

Recent Developments:

In May 2022, Priothera was granted approval by the US Food and Drug Administration to begin a Phase 2b/3 research using mocravimod in patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.

Akari Therapeutics, Plc

Otsuka America Pharmaceutical, Inc.

Merck KGaA

Takeda Pharmaceutical Company Limited

Lonza

GlaxoSmithKline plc

Novartis AG

Merck & Co., Inc.

Sanofi

FUJIFILM Holdings Corporation

bluebird bio, Inc.

Pluristem Therapeutics Inc.

Regen Biopharma Inc.

Kiadis Pharma

Taiga Biotechnologies, Inc.

CellGenix GmbH

Escape Therapeutics, Inc.

Talaris Therapeutics

Marker Therapeutics, Inc.

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY TRANSPLANT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous
  • Allogeneic
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cord Stem Cell Transplant
  • Bone Marrow Stem Cell Transplant
  • Peripheral Stem Cell Transplant
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Leukemia
  • Lymphoproliferative Disorders
  • Non-Malignant Disorders
  • Others

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Offline
  • Online

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Clinics

GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Hematopoietic Stem Cell Transplantation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Hematopoietic Stem Cell Transplantation Market Snippet by Transplant Type
    • 2.1.2.Hematopoietic Stem Cell Transplantation Market Snippet by Application
    • 2.1.3.Hematopoietic Stem Cell Transplantation Market Snippet by Indication
    • 2.1.4.Hematopoietic Stem Cell Transplantation Market Snippet by Distribution Channel
    • 2.1.5.Hematopoietic Stem Cell Transplantation Market Snippet by End User
    • 2.1.6.Hematopoietic Stem Cell Transplantation Market Snippet by Country
    • 2.1.7.Hematopoietic Stem Cell Transplantation Market Snippet by Region
  • 2.2.Competitive Insights

3.Hematopoietic Stem Cell Transplantation Key Market Trends

  • 3.1.Hematopoietic Stem Cell Transplantation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Hematopoietic Stem Cell Transplantation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Hematopoietic Stem Cell Transplantation Market Opportunities
  • 3.4.Hematopoietic Stem Cell Transplantation Market Future Trends

4.Hematopoietic Stem Cell Transplantation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Hematopoietic Stem Cell Transplantation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Hematopoietic Stem Cell Transplantation Market Landscape

  • 6.1.Hematopoietic Stem Cell Transplantation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Hematopoietic Stem Cell Transplantation Market - By Transplant Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Transplant Type, 2023 & 2032 (%)
    • 7.1.2.Autologous
    • 7.1.3.Allogeneic
    • 7.1.4.Others

8.Hematopoietic Stem Cell Transplantation Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cord Stem Cell Transplant
    • 8.1.3.Bone Marrow Stem Cell Transplant
    • 8.1.4.Peripheral Stem Cell Transplant
    • 8.1.5.Others

9.Hematopoietic Stem Cell Transplantation Market - By Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2.Leukemia
    • 9.1.3.Lymphoproliferative Disorders
    • 9.1.4.Non-Malignant Disorders
    • 9.1.5.Others

10.Hematopoietic Stem Cell Transplantation Market - By Distribution Channel

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 10.1.2.Offline
    • 10.1.3.Online

11.Hematopoietic Stem Cell Transplantation Market - By End User

  • 11.1.Overview
    • 11.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2.Retail Pharmacy
    • 11.1.3.Hospital Pharmacy
    • 11.1.4.Specialty Clinics

12.Hematopoietic Stem Cell Transplantation Market- By Geography

  • 12.1.Introduction
    • 12.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2.North America
    • 12.2.1.Overview
    • 12.2.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in North America
    • 12.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4.North America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.2.7.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.8.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9.U.S.
      • 12.2.9.1.Overview
      • 12.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3.U.S. Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.2.9.6.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.9.7.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10.Canada
      • 12.2.10.1.Overview
      • 12.2.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3.Canada Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.2.10.6.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.2.10.7.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.Europe
    • 12.3.1.Overview
    • 12.3.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Europe
    • 12.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4.Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.3.7.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.8.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9.Germany
      • 12.3.9.1.Overview
      • 12.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3.Germany Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.9.6.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.9.7.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10.Italy
      • 12.3.10.1.Overview
      • 12.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3.Italy Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.10.6.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.10.7.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11.United Kingdom
      • 12.3.11.1.Overview
      • 12.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3.United Kingdom Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.11.6.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.11.7.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12.France
      • 12.3.12.1.Overview
      • 12.3.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3.France Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.12.6.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.12.7.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13.Russia
      • 12.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2.Russia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.13.5.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.13.6.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14.Netherlands
      • 12.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2.Netherlands Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.14.5.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.14.6.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15.Sweden
      • 12.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2.Sweden Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.15.5.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.15.6.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16.Poland
      • 12.3.16.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2.Poland Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.16.5.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.16.6.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17.Rest of Europe
      • 12.3.17.1.Overview
      • 12.3.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3.Rest of the Europe Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.3.17.6.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.3.17.7.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.Asia Pacific (APAC)
    • 12.4.1.Overview
    • 12.4.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Asia Pacific
    • 12.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4.Asia Pacific Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.4.7.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.8.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9.India
      • 12.4.9.1.Overview
      • 12.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3.India Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.9.6.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.9.7.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10.China
      • 12.4.10.1.Overview
      • 12.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3.China Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.10.6.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.10.7.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11.Japan
      • 12.4.11.1.Overview
      • 12.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3.Japan Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.11.6.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.11.7.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12.South Korea
      • 12.4.12.1.Overview
      • 12.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3.South Korea Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.12.6.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.12.7.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13.Australia
      • 12.4.13.1.Overview
      • 12.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3.Australia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.13.6.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.13.7.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14.Thailand
      • 12.4.14.1.Overview
      • 12.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3.Thailand Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.14.6.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.14.7.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15.Indonesia
      • 12.4.15.1.Overview
      • 12.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3.Indonesia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.15.6.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.15.7.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16.Philippines
      • 12.4.16.1.Overview
      • 12.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3.Philippines Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.16.6.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.16.7.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17.Rest of APAC
      • 12.4.17.1.Overview
      • 12.4.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3.Rest of APAC Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.4.17.6.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.4.17.7.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.Latin America
    • 12.5.1.Overview
    • 12.5.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Latin America
    • 12.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4.Latin America Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.5.7.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.8.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9.Brazil
      • 12.5.9.1.Overview
      • 12.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3.Brazil Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.9.6.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.9.7.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10.Mexico
      • 12.5.10.1.Overview
      • 12.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3.Mexico Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.10.6.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.10.7.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11.Argentina
      • 12.5.11.1.Overview
      • 12.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3.Argentina Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.11.6.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.11.7.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12.Colombia
      • 12.5.12.1.Overview
      • 12.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3.Colombia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.12.6.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.12.7.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13.Rest of LATAM
      • 12.5.13.1.Overview
      • 12.5.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3.Rest of LATAM Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.5.13.6.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.5.13.7.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.Middle East and Africa
    • 12.6.1.Overview
    • 12.6.2.Hematopoietic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
    • 12.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4.Middle East and Africa Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
    • 12.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 12.6.7.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.8.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9.Saudi Arabia
      • 12.6.9.1.Overview
      • 12.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3.Saudi Arabia Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.9.6.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.9.7.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10.United Arab Emirates
      • 12.6.10.1.Overview
      • 12.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3.United Arab Emirates Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.10.6.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.10.7.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11.Israel
      • 12.6.11.1.Overview
      • 12.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3.Israel Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.11.6.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.11.7.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12.Turkey
      • 12.6.12.1.Overview
      • 12.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3.Turkey Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.12.6.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.12.7.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13.Algeria
      • 12.6.13.1.Overview
      • 12.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3.Algeria Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.13.6.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.13.7.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14.Egypt
      • 12.6.14.1.Overview
      • 12.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3.Egypt Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.14.6.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.14.7.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15.Rest of MEA
      • 12.6.15.1.Overview
      • 12.6.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3.Rest of MEA Market Size and Forecast, By Transplant Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 12.6.15.6.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 12.6.15.7.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13.Key Vendor Analysis- Hematopoietic Stem Cell Transplantation Industry

  • 13.1.Competitive Dashboard
  • 13.2.Company Profiles
    • 13.2.1.Pfizer Inc.
    • 13.2.2.Akari Therapeutics, Plc
    • 13.2.3.Otsuka America Pharmaceutical, Inc.
    • 13.2.4.Merck KGaA
    • 13.2.5.Takeda Pharmaceutical Company Limited
    • 13.2.6.Lonza
    • 13.2.7.GlaxoSmithKline plc
    • 13.2.8.Novartis AG
    • 13.2.9.Merck & Co., Inc.
    • 13.2.10.Sanofi
    • 13.2.11.FUJIFILM Holdings Corporation
    • 13.2.12.bluebird bio, Inc.
    • 13.2.13.Pluristem Therapeutics Inc.
    • 13.2.14.Regen Biopharma Inc.
    • 13.2.15.Kiadis Pharma
    • 13.2.16.Taiga Biotechnologies, Inc.
    • 13.2.17.CellGenix GmbH
    • 13.2.18.Escape Therapeutics, Inc.
    • 13.2.19.Talaris Therapeutics
    • 13.2.20.Marker Therapeutics, Inc.

14.360 Degree Analyst View

15.Appendix

  • 15.1.Research Applicationology
  • 15.2.References
  • 15.3.Abbreviations
  • 15.4.Disclaimer
  • 15.5.Contact Usq